Synmosa Biopharma Corporation (TPEX:4114)
Taiwan · Delayed Price · Currency is TWD 29.40
0.00 (0.00%)
Oct 21, 2026, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 15.91 billion as of October 20, 2026. It is the 14,820th most valuable company in the world and the 521st biggest in Taiwan. Its market cap has decreased by 6.55% in one year.
Market Cap
15.91B
Enterprise Value
17.68B
Revenue
6.68B
Global Rank
Country Rank
#521 Taiwan
PE Ratio
19.24
ChartMarket Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.91B, an increase of 2,626.60%. That is a compound annual growth rate of 17.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 15.91B | -2.08% |
| Dec 31, 2025 | 16.25B | 12.06% |
| Dec 31, 2024 | 14.50B | -1.41% |
| Dec 29, 2023 | 14.71B | -8.20% |
| Dec 30, 2022 | 16.02B | 128.36% |
| Dec 30, 2021 | 7.02B | 2.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 23.65B |
| Handa Pharmaceuticals | 21.29B |
| TTY Biopharm Company | 20.04B |
| YungShin Global Holding | 15.69B |
| ScinoPharm Taiwan | 15.18B |
| Grape King Bio | 12.73B |
| Foresee Pharmaceuticals | 12.15B |
| Standard Chemical & Pharmaceutical | 10.17B |